EW vs LNKB · P/E 47, rev $3.39B vs P/E 7.9, rev $167.6M
Edwards Lifesciences Corp (EW) versus LINKBANCORP Inc (LNKB) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
LINKBANCORP Inc (LNKB) is a banks - regional company listed on US.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LNKB revenue for 2024-12-31 was $167.6M. Net income was $26.2M. Revenue was up 152.8% from 2023-12-31 to 2024-12-31. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LNKB currently screens at market cap $286.7M and trailing P/E 7.9.
Not investment advice. Open the EW and LNKB stock pages for the full models.
Not investment advice.